GlassScriptPhysician profile
Ciao Newman
NPI 1922133206
$5,870.98
in general payments reported to CMS, 2019-2025
49 companies · $851 in 2025
The $851 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $907 · 2020: $829 · 2021: $768 · 2022: $734 · 2023: $919 · 2024: $862 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,631.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,029.97 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $652.79 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $595.01 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $591.99 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Abbvie INC. | $465.06 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $266.38 | 2019-2025 | Jardiance |
| Pfizer INC. | $265.84 | 2020-2025 | |
| Abbott Laboratories | $202.59 | 2020-2025 | Freestyle Libre, Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $133.38 | 2021-2023 | |
| Shield Therapeutics INC | $125.94 | 2023-2025 | Accrufer |
| Amarin Pharma, INC. | $117.95 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $114.20 | 2023-2024 | Rexulti |
| Xeris Pharmaceuticals, INC. | $105.02 | 2021-2025 | Gvoke Hypopen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.26 | 2019-2025 | Xifaxan, Trulance |
| Allergan, INC. | $72.26 | 2019-2020 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ciao Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.